Leukemia, Myeloid Clinical Trials in Winston-Salem, North Carolina
5 recruitingWinston-Salem, North Carolina
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Janssen Research & Development, LLC600 enrolled239 locationsNCT06852222
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Multiple MyelomaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more
Sumitomo Pharma America, Inc.606 enrolled104 locationsNCT04988555
Recruiting
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
Leukemia, Myeloid, Acute
Wake Forest University Health Sciences50 enrolled2 locationsNCT06580106
Recruiting
Phase 2
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
Leukemia, Myeloid, Acute
OncoVerity, Inc.120 enrolled31 locationsNCT06384261
Recruiting
Phase 1Phase 2
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Delta-Fly Pharma, Inc.39 enrolled4 locationsNCT06382168